Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > About KCI > News & Media > News Archive > KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today
Print

KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today

Released : September 7th 2011

KCI today announced that its V.A.C.Via Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIOSept. 7, 2011— Kinetic Concepts, Inc. (NYSE:KCI) today announced that its V.A.C.Via Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.

Podiatry Today ranked V.A.C.Via second among innovative devices for its quarter-sized, virtually silent pump that makes it a patient-friendly treatment option. The publication also recognized V.A.C.Via System's seven-day performance on one battery charge, as opposed to heavy NiCd rechargeable batteries found in other NPWT devices, as another factor leading to its innovative ranking.

The V.A.C.Via Therapy System is a next-generation negative pressure wound therapy (NPWT) solution that offers clinicians and patients an off-the-shelf, portable healing technology that delivers all of the benefits of V.A.C.® Therapy. The technology provides a wound healing environment for low- to moderate-exudating wounds while offering simplicity, mobility and convenience to both physicians and patients.

"Miniaturizing V.A.C.® Therapy in the form of the V.A.C.Via System ensures trusted, cost-effective outcomes with added mobility," said Mike Genau, global president, KCI's Active Healing Solutions. "Helping patients return to their normal routine, while receiving world-class wound care takes industry leading research and developers who put patients first — that is at the heart of what we do at KCI."

The publication also highlights the V.A.C.Via System's small size, light weight and portability, with one physician remarking that it can be discreetly attached to a patient's waist throughout the duration of treatment, then recycled or disposed of by the patient at the end of seven days.

For more information please visit www.vacvia.com or www.kci1.com.

About KCI

Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world. The company employs approximately 7,100 people and markets its products in more than 20 countries. For more information about KCI and how its products are changing the practice of medicine, visit www.KCI1.com.

FOR MORE INFORMATION, CONTACT:

Kinetic Concepts, Inc.
Media Relations:
Media@kci1.com for journalists only.
or
Investors Relations:
IR@kci1.com for Investor Relations inquiries.

 


  • KCI Express
  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Policy | Contact Us | News Feed


Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.